Nichi-Iko Pharmaceutical 9M Group Net Income 2.65B Yen 4541 JP

Nichi-Iko Pharmaceutical (4541) announced nine-month group earnings for the period ended Aug. 31. Figures other than earnings per share are in millions of yen.

================================================================================

Operating Current Net Earnings

Revenue Profit Profit Income Per Share ================================================================================ Nine-Month Results 56524.00 5262.00 5084.00 2651.00 69.94 Year-Earlier Period 46904.00 5047.00 4831.00 2732.00 87.27 Versus Results 20.50% 4.30% 5.20% -3.00% -20.00% Full-Year Estimates 78000.00 7800.00 7500.00 4000.00 103.92 ================================================================================

To contact the editor responsible for this story: Teo Chian Wei at +81-3-3201-3623 or cwteo@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.